Forbes William P
- SEC CIK
- 0001314760
No open-market purchases or sales filed in the past year.
Current role at each company
- HRTX Heron Therapeutics, Inc.EVP, Chief Development Officeras of Aug 3, 2026
- XAIR Beyond Air, Inc.Directoras of Nov 6, 2025
- TRVI Trevi Therapeutics, Inc.Chief Development Officeras of Jul 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Forbes William P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HRTX Heron Therapeutics, Inc.
EVP, Chief Development Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 (view filing) | Nov 17 | 4 days | Forbes William PEVP, Chief Development Officer | PPurchase | +25.0K | $1.09 | +$27.3K | +46.3%79.0K after | |
| Nov 20, 2023 (view filing) | Nov 16 | 4 days | Forbes William PEVP, Chief Development Officer | PPurchase | +50.0K | $0.94 | +$47.0K | +1,250.0%54.0K after |
XAIR Beyond Air, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 (view filing) | Mar 31 | 3 days | Forbes William PDirector | PPurchase | +5.00K | $6.67 | +$33.4K | +50.7%14.9K after | |
| Mar 20, 2023 (view filing) | Mar 17 | 3 days | Forbes William PDirector | PPurchase | +5.00K | $6.46 | +$32.3K | +103.0%9.86K after |